康缘药业
(600557)
| 流通市值：84.41亿 | | | 总市值：84.41亿 |
| 流通股本：5.66亿 | | | 总股本：5.66亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,342,688,380.58 | 1,641,577,928.56 | 877,554,089.34 | 3,897,668,541.61 |
| 营业收入 | 2,342,688,380.58 | 1,641,577,928.56 | 877,554,089.34 | 3,897,668,541.61 |
| 二、营业总成本 | 2,141,450,228.75 | 1,488,675,905.49 | 776,267,643.69 | 3,601,511,513.81 |
| 营业成本 | 715,329,569.67 | 478,019,238.39 | 226,572,240.8 | 1,043,897,392 |
| 税金及附加 | 36,636,915.36 | 26,726,060.63 | 16,072,007.56 | 60,571,592.66 |
| 销售费用 | 806,936,366.24 | 571,377,252.05 | 329,015,960.82 | 1,535,179,459.1 |
| 管理费用 | 235,012,095.87 | 166,768,880.59 | 75,848,099.77 | 318,162,596.88 |
| 研发费用 | 351,637,702.25 | 246,565,004.87 | 131,914,970.39 | 638,103,967.37 |
| 财务费用 | -4,102,420.64 | -780,531.04 | -3,155,635.65 | 5,596,505.8 |
| 其中:利息费用 | 9,062,470.57 | 6,036,617.18 | 3,049,590.93 | 22,297,041.41 |
| 其中:利息收入 | 14,667,693.23 | 7,404,338.19 | 6,236,054.49 | 17,389,064.63 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 4,904,974.63 | 4,800,451 | 750,780.99 | 20,520,880.49 |
| 资产处置收益 | 421,945.72 | -20,480.39 | -6,931.75 | 1,083,999.48 |
| 资产减值损失(新) | - | - | - | -20,741,965.38 |
| 信用减值损失(新) | 246,304.98 | -1,157,749.8 | -1,169,564.77 | 3,240,115.75 |
| 其他收益 | 53,152,156.34 | 28,079,094.46 | 3,462,526.83 | 84,257,281.89 |
| 四、营业利润 | 259,963,533.5 | 184,603,338.34 | 104,323,256.95 | 384,517,340.03 |
| 加:营业外收入 | 833,441.5 | 301,626.74 | 188,243.64 | 11,983,081.49 |
| 减:营业外支出 | 7,655,125.64 | 4,122,557.37 | 725,758.05 | 11,736,443.82 |
| 五、利润总额 | 253,141,849.36 | 180,782,407.71 | 103,785,742.54 | 384,763,977.7 |
| 减:所得税费用 | 45,444,958.84 | 32,074,037.44 | 18,233,357.36 | 3,840,968.58 |
| 六、净利润 | 207,696,890.52 | 148,708,370.27 | 85,552,385.18 | 380,923,009.12 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 207,696,890.52 | 148,708,370.27 | 85,552,385.18 | 380,923,009.12 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 199,641,746.77 | 142,369,353.66 | 83,412,980.21 | 391,862,071.18 |
| 少数股东损益 | 8,055,143.75 | 6,339,016.61 | 2,139,404.97 | -10,939,062.06 |
| 扣除非经常损益后的净利润 | 160,124,620.74 | 119,995,673.79 | 81,998,942.57 | 363,186,857.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.35 | 0.25 | 0.15 | 0.68 |
| (二)稀释每股收益 | 0.35 | 0.25 | 0.15 | 0.68 |
| 九、综合收益总额 | 207,696,890.52 | 148,708,370.27 | 85,552,385.18 | 380,923,009.12 |
| 归属于母公司股东的综合收益总额 | 199,641,746.77 | 142,369,353.66 | 83,412,980.21 | 391,862,071.18 |
| 归属于少数股东的综合收益总额 | 8,055,143.75 | 6,339,016.61 | 2,139,404.97 | -10,939,062.06 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-30 | 2025-04-03 |
| 审计意见(境内) | | | | 标准无保留意见 |